← PFIZER INC
| Annual Trend | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||||
| Current assets: | |||||||||||
| Cash and Cash Equivalents, at Carrying Value | $2.6b | $1.3b | $1.1b | $1.3b | $1.8b | $1.9b | $416.0m | $2.9b | $1.0b | $1.1b | |
| Cash and cash equivalents | $2.6b | $1.3b | $1.1b | $1.3b | $1.8b | $1.9b | $416.0m | $2.9b | $1.0b | $1.1b | |
| Other current assets | $2.2b | $2.3b | $2.5b | $2.6b | $3.4b | $3.8b | $5.0b | $5.3b | $4.3b | $2.8b | |
| Short-term Investments | $15.3b | $18.6b | $17.7b | $8.5b | $10.4b | $29.1b | $22.3b | $9.8b | $19.4b | $12.5b | |
| Trade accounts receivable, net of allowance for doubtful accounts: 2025—$427; 2024—$438 | $8.2b | $8.2b | $8.0b | $8.7b | $7.9b | $11.5b | $11.0b | $11.2b | $11.5b | $11.9b | |
| Inventory, Net | $6.8b | $7.6b | $7.5b | $8.3b | $8.0b | $9.1b | $9.0b | $10.2b | $10.9b | $10.7b | |
| Assets, Current | $38.9b | $41.1b | $49.9b | $32.8b | $35.1b | $59.7b | $51.3b | $43.3b | $50.4b | $42.9b | |
| Total current assets | $38.9b | $41.1b | $49.9b | $32.8b | $35.1b | $59.7b | $51.3b | $43.3b | $50.4b | $42.9b | |
| Long-term investments | $7.1b | $7.0b | $2.8b | $3.0b | $3.4b | $5.1b | $4.0b | $3.7b | $2.0b | $1.6b | |
| Property, Plant and Equipment, Net | $13.3b | $13.9b | $13.4b | $14.0b | $13.9b | $14.9b | $16.3b | $18.9b | $18.4b | $19.3b | |
| Goodwill | $54.4b | $56.0b | $53.4b | $58.7b | $49.6b | $49.2b | $51.4b | $67.8b | $68.5b | $71.3b | |
| Identifiable intangible assets, net | $52.6b | $48.7b | $35.2b | $35.4b | $28.5b | $25.1b | $43.4b | $64.9b | $55.4b | $53.7b | |
| Intangible Assets, Net (Excluding Goodwill) | $52.6b | $48.7b | $35.2b | $35.4b | $28.5b | $25.1b | $43.4b | $64.9b | $55.4b | $53.7b | |
| Operating Lease, Right-of-Use Asset | — | — | — | $1.3b | $1.4b | $2.8b | $3.0b | $2.9b | $2.3b | $2.2b | |
| Other Assets, Noncurrent | $3.3b | $3.2b | $2.8b | $4.5b | $4.6b | $7.7b | $13.2b | $12.5b | $9.8b | $9.6b | |
| Other noncurrent assets | $3.3b | $3.2b | $2.8b | $4.5b | $4.6b | $7.7b | $13.2b | $12.5b | $9.8b | $9.6b | |
| Additional Financial Items | |||||||||||
| Accounts Receivable, after Allowance for Credit Loss, Current | $8.2b | $8.2b | $8.0b | $8.7b | $7.9b | $11.5b | $11.0b | $11.2b | $11.5b | $11.9b | |
| Current tax assets | $3.0b | $3.0b | $3.4b | $3.3b | $3.3b | $4.3b | $3.6b | $4.0b | $3.3b | $4.0b | |
| Deferred revenues | — | — | — | — | $1.1b | $3.1b | $2.5b | $2.7b | $1.5b | $784.0m | |
| Income taxes payable | $437.0m | $477.0m | $1.3b | $980.0m | $1.0b | $1.3b | $1.6b | $2.3b | $2.9b | $3.1b | |
| Noncurrent deferred tax assets and other noncurrent tax assets | $1.8b | $1.9b | $1.9b | $2.1b | $2.4b | $3.3b | $6.7b | $3.7b | $8.7b | $9.7b | |
| Other current liabilities | $11.0b | $11.1b | $10.8b | $11.1b | $12.6b | $24.9b | $22.6b | $20.5b | $19.7b | $18.6b | |
| Other taxes payable | $4.0b | $18.7b | $14.7b | $12.1b | $11.6b | $11.3b | $9.8b | $8.5b | $6.1b | $3.6b | |
| Total Pfizer Inc. shareholders’ equity | $59.5b | $71.3b | $63.4b | $63.1b | $63.2b | $77.2b | $95.7b | $89.0b | $88.2b | $86.5b | |
| Total equity | $59.8b | $71.7b | $63.8b | $63.4b | $63.5b | $77.5b | $95.9b | $89.3b | $88.5b | $86.8b | |
| Assets | $171.6b | $171.8b | $159.4b | $167.5b | $154.2b | $181.5b | $197.2b | $226.5b | $213.4b | $208.2b | |
| Total assets | $171.6b | $171.8b | $159.4b | $167.5b | $154.2b | $181.5b | $197.2b | $226.5b | $213.4b | $208.2b | |
| LIABILITIES AND EQUITY | |||||||||||
| Current liabilities: | |||||||||||
| Accounts Payable, Current | $4.5b | $4.7b | $4.7b | $4.2b | $4.3b | $5.6b | $6.8b | $6.7b | $5.6b | $5.2b | |
| Accrued compensation and related items | $2.5b | $2.2b | $2.4b | $2.7b | $3.1b | $3.3b | $3.4b | $2.8b | $3.8b | $3.6b | |
| Dividends Payable, Current | $1.9b | $2.0b | $2.0b | $2.1b | $2.2b | $2.2b | $2.3b | $2.4b | $2.4b | $2.4b | |
| Dividends payable | $2k | $2k | $2k | $2k | $2k | $2k | $2k | $2k | $2k | $2k | |
| Long-term Debt, Current Maturities | $4.2b | $3.5b | $4.8b | $1.5b | $2.0b | $1.6b | $2.6b | $2.3b | $3.7b | $3.0b | |
| Long-term Debt, Excluding Current Maturities | $31.4b | $33.5b | $32.9b | $36.0b | $37.1b | $36.2b | $32.9b | $61.5b | $57.4b | $61.6b | |
| Operating Lease, Liability, Current | — | — | — | $276.0m | $321.0m | $449.0m | $620.0m | $527.0m | $356.0m | $330.0m | |
| Operating Lease, Liability, Noncurrent | — | — | — | $1.0b | $1.1b | $2.5b | $2.6b | $2.6b | $2.3b | $2.3b | |
| Short-term borrowings, including current portion of long-term debt: 2025—$2,997; 2024—$3,747 | $10.7b | $10.0b | $8.8b | $16.2b | $2.7b | $2.2b | $2.9b | $10.3b | $6.9b | $3.2b | |
| Trade accounts payable | $4.5b | $4.7b | $4.7b | $4.2b | $4.3b | $5.6b | $6.8b | $6.7b | $5.6b | $5.2b | |
| Liabilities, Current | $31.1b | $30.4b | $31.9b | $37.3b | $25.9b | $42.7b | $42.1b | $47.8b | $43.0b | $37.0b | |
| Total current liabilities | $31.1b | $30.4b | $31.9b | $37.3b | $25.9b | $42.7b | $42.1b | $47.8b | $43.0b | $37.0b | |
| Deferred Income Tax Liabilities, Net | — | $3.9b | $3.7b | $5.6b | $4.1b | $349.0m | $1.0b | $640.0m | $2.1b | $2.4b | |
| Noncurrent deferred tax liabilities | $30.8b | $3.9b | $3.7b | $5.6b | $4.1b | $349.0m | $1.0b | $640.0m | $2.1b | $2.4b | |
| Other Liabilities, Noncurrent | $6.3b | $6.1b | $5.8b | $6.3b | $6.7b | $9.7b | $13.2b | $16.5b | $14.2b | $14.7b | |
| Other noncurrent liabilities | $6.3b | $6.1b | $5.8b | $6.3b | $6.7b | $9.7b | $13.2b | $16.5b | $14.2b | $14.7b | |
| Pension and postretirement benefit obligations | — | — | — | — | — | $3.7b | $2.2b | $2.2b | $2.1b | $2.0b | |
| Deferred Tax Liabilities, Net | $30.1b | $3.2b | $2.9b | $4.7b | $3.1b | — | — | — | — | — | |
| Liabilities | $111.8b | $100.1b | $95.7b | $104.0b | $90.8b | $104.0b | $101.3b | $137.2b | $124.9b | $121.4b | |
| Total liabilities | $111.8b | $100.1b | $95.7b | $104.0b | $90.8b | $104.0b | $101.3b | $137.2b | $124.9b | $121.4b | |
| Stockholders’ equity: | |||||||||||
| Accumulated Other Comprehensive Income (Loss), Net of Tax | ($11.0b) | ($9.3b) | ($11.3b) | ($11.6b) | ($11.7b) | ($5.9b) | ($8.3b) | ($8.0b) | ($7.8b) | ($8.1b) | |
| Accumulated other comprehensive loss | ($11.0b) | ($9.3b) | ($11.3b) | ($11.6b) | ($11.7b) | ($5.9b) | ($8.3b) | ($8.0b) | ($7.8b) | ($8.1b) | |
| Additional Paid in Capital | $82.7b | $84.3b | $86.3b | $87.4b | $88.7b | $90.6b | $91.8b | $92.6b | $93.6b | $94.5b | |
| Common Stock, Value, Issued | $461.0m | $464.0m | $467.0m | $468.0m | $470.0m | $473.0m | $476.0m | $478.0m | $480.0m | $481.0m | |
| Common stock, $0.05 par value; 12,000 shares authorized; issued: 2025—9,621; 2024—9,593 | $461.0m | $464.0m | $467.0m | $468.0m | $470.0m | $473.0m | $476.0m | $478.0m | $480.0m | $481.0m | |
| Preferred Stock, Value, Issued | $24.0m | $21.0m | $19.0m | $17.0m | $0 | $0 | $0 | $0 | — | — | |
| Retained Earnings (Accumulated Deficit) | $71.8b | $85.3b | $89.6b | $97.7b | $96.8b | $103.4b | $125.7b | $118.4b | $116.7b | $114.6b | |
| Treasury stock, shares at cost: 2025—3,935; 2024—3,926 | — | — | — | — | — | — | — | ($114.5b) | ($114.8b) | ($115.0b) | |
| Stockholders' Equity Attributable to Parent | $59.5b | $71.3b | $63.4b | $63.1b | $63.2b | $77.2b | $95.7b | $89.0b | $88.2b | $86.5b | |
| Equity attributable to noncontrolling interests | $296.0m | $348.0m | $351.0m | $303.0m | $235.0m | $262.0m | $256.0m | $274.0m | $294.0m | $299.0m | |
| Stockholders' Equity Attributable to Noncontrolling Interest | $296.0m | $348.0m | $351.0m | $303.0m | $235.0m | $262.0m | $256.0m | $274.0m | $294.0m | $299.0m | |
| Liabilities and Equity | $171.6b | $171.8b | $159.4b | $167.5b | $154.2b | $181.5b | $197.2b | $226.5b | $213.4b | $208.2b | |
| Total liabilities and equity | $171.6b | $171.8b | $159.4b | $167.5b | $154.2b | $181.5b | $197.2b | $226.5b | $213.4b | $208.2b |
Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.